Navellier & Associates’s Braskem BAK Stock Holding History

Navellier & Associates’s Portfolio BAK Stock Details BAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-5,341	Closed	-$69K	–	246
2016 Q1	$69K	Buy	+5,341	New	+$68.2K	0.01%	208

Other funds holding BAK

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

HSA

Hussman Strategic Advisors Ellicott City, Maryland $463M AUM 16% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Navellier & Associates's BAK Position: Q2 2016 in Review

Navellier & Associates sold out of Braskem (BAK) in Q2 2016, closing a stake of 5,341 shares — an estimated $69K sold.

Navellier & Associates first reported a position in BAK in Q1 2016 and held it in 1 quarter. The position peaked at $69K in Q1 2016. 84 funds tracked by Wall St. Rank hold BAK as of Q2 2016.

Navellier & Associates reported no remaining Braskem position as of Q2 2016 after selling out during the quarter.
Navellier & Associates sold 5,341 Braskem shares in Q2 2016, an estimated $69K.
Navellier & Associates first reported a position in Braskem in Q1 2016 and held it in 1 quarter.
Navellier & Associates's Braskem position peaked at $69K in Q1 2016.
84 funds tracked by Wall St. Rank held Braskem as of Q2 2016.

Based on Navellier & Associates's 13F filing for Q2 2016, filed 3 Aug 2016.